Detalhe da pesquisa
1.
Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy.
Respir Res
; 25(1): 156, 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581044
2.
LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinoma.
Future Oncol
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38695479
3.
Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab.
Cancer Immunol Immunother
; 71(7): 1747-1756, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839373
4.
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors.
Neuroendocrinology
; 112(6): 537-546, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348346
5.
Long-term avelumab in advanced non-small-cell lung cancer: summaries and post hoc analyses from JAVELIN Solid Tumor.
Future Oncol
; 18(11): 1333-1342, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35144482
6.
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(2): 198-211, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33476593
7.
KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma.
Future Oncol
; 17(10): 1143-1153, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33533655
8.
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
Gut
; 69(3): 531-539, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31101691
9.
Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial.
Br J Cancer
; 122(7): 957-962, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015513
10.
The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).
Oncologist
; 25(3): e451-e459, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162804
11.
The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/ß2m overexpression.
Mod Pathol
; 33(3): 468-482, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409873
12.
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance.
Gastric Cancer
; 23(1): 73-81, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31267360
13.
Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer.
Future Oncol
; 16(12): 749-762, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228198
14.
Impact of magnetic field regulation in conjunction with the volumetric repainting technique on the spot positions and beam range in pencil beam scanning proton therapy.
J Appl Clin Med Phys
; 21(11): 124-131, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33058380
15.
KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer.
Future Oncol
; 15(10): 1057-1066, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30735435
16.
Development and long-term stability of a comprehensive daily QA program for a modern pencil beam scanning (PBS) proton therapy delivery system.
J Appl Clin Med Phys
; 20(4): 29-44, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30920146
17.
Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
J Appl Clin Med Phys
; 20(8): 36-46, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31343826
18.
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC).
Cancer
; 124(24): 4667-4675, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383906
19.
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study.
Br J Cancer
; 118(3): 325-330, 2018 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29169182
20.
"Emergency" multidisciplinary team meeting in cancer: a first feedback from a care team.
J Transl Med
; 21(1): 767, 2023 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904183